seed
Stage
2012
Founded
1
Investors
About
NunaBio provides a next-generation cell-free enzymatic platform for the synthesis, assembly, and amplification of high-fidelity synthetic DNA at gram scale within days, targeting biotech, pharma, and government partners with multiple DNA formats and distributed micro-foundry deployment.
Explore NunaBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.